Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 819232, 12 pages
http://dx.doi.org/10.1155/2015/819232
Research Article

Captopril Pretreatment Produces an Additive Cardioprotection to Isoflurane Preconditioning in Attenuating Myocardial Ischemia Reperfusion Injury in Rabbits and in Humans

1Department of Anesthesiology, Haikou Municipal Hospital, Affiliated Haikou Hospital Xiangya School of Medicine, Central South University, Haikou 570208, China
2Department of Anesthesiology, The University of Hong Kong, Hong Kong
3Department of Anesthesiology, Hainan Municipal Corps Hospital, Chinese People’s Armed Police Force, Haikou 570203, China
4Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
5Department of Anesthesiology, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524023, China

Received 23 November 2014; Accepted 27 December 2014

Academic Editor: Huang-Ping Yu

Copyright © 2015 Yi Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Hawkes, M. Nowak, B. Bidstrup, and R. Speare, “Outcomes of coronary artery bypass graft surgery,” Vascular Health and Risk Management, vol. 2, no. 4, pp. 477–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Cao, T. Yang, S. Yu, G. Sun, C. Gu, and D. Yi, “Relationships of adiponectin with markers of systemic inflammation and insulin resistance in infants undergoing open cardiac surgery,” Mediators of Inflammation, vol. 2013, Article ID 187940, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Genereux, D. J. Cohen, M. Mack et al., “Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement,” Journal of the American College of Cardiology, vol. 64, no. 24, pp. 2605–2615, 2014. View at Publisher · View at Google Scholar
  4. A. P. Furnary, G. Gao, G. L. Grunkemeier et al., “Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting,” Journal of Thoracic and Cardiovascular Surgery, vol. 125, no. 5, pp. 1007–1021, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Yusuf, D. Zucker, P. Peduzzi et al., “Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration,” The Lancet, vol. 344, no. 8922, pp. 563–570, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Huang, X. Zhong, M. G. Irwin et al., “Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients,” Clinical Science, vol. 121, no. 2, pp. 57–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Belhomme, J. Peynet, M. Louzy, J.-M. Launay, M. Kitakaze, and P. Menasché, “Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery,” Circulation, vol. 100, no. 19, supplement, pp. II340–II344, 1999. View at Google Scholar · View at Scopus
  8. L. G. Kevin, P. Katz, A. K. S. Camara, E. Novalija, M. L. Riess, and D. F. Stowe, “Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts,” Anesthesiology, vol. 99, no. 2, pp. 385–391, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Mio, M. W. Bienengraeber, J. Marinovic et al., “Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity,” Anesthesiology, vol. 108, no. 4, pp. 612–620, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Tanaka, F. Kehl, W. Gu et al., “Isoflurane-induced preconditioning is attenuated by diabetes,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 282, no. 6, pp. H2018–H2023, 2002. View at Google Scholar · View at Scopus
  11. G. Clermont, C. Vergely, S. Jazayeri et al., “Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass,” Anesthesiology, vol. 96, no. 1, pp. 80–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. P. A. Checchia, R. A. Bronicki, J. T. Muenzer et al., “Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children—a randomized trial,” Journal of Thoracic and Cardiovascular Surgery, vol. 146, no. 3, pp. 530–536, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Millucci, L. Ghezzi, E. Paccagnini et al., “Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient,” Mediators of Inflammation, vol. 2014, Article ID 258471, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Börgermann, I. Friedrich, S. Flohé et al., “Tumor necrosis factor-α production in whole blood after cardiopulmonary bypass: downregulation caused by circulating cytokine-inhibitory activities,” Journal of Thoracic and Cardiovascular Surgery, vol. 124, no. 3, pp. 608–617, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Khosravi, K. Ka, T. Huang et al., “Tumor necrosis factor-α and interleukin-6: potential interorgan inflammatory mediators contributing to destructive periodontal disease in obesity or metabolic syndrome,” Mediators of Inflammation, vol. 2013, Article ID 728987, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. P. H. Lou, E. Lucchinetti, L. Zhang et al., “Loss of Intralipid but not sevoflurane-mediated cardioprotection in early type-2 diabetic hearts of fructose-fed rats: importance of ROS signaling,” PLoS ONE, vol. 9, no. 8, Article ID e104971, 2014. View at Publisher · View at Google Scholar
  17. H. Wang, L. Wang, N. Li et al., “Subanesthetic isoflurane reduces zymosan-induced inflammation in murine Kupffer cells by inhibiting ROS-activated p38 MAPK/NF-κB signaling,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 851692, 13 pages, 2014. View at Publisher · View at Google Scholar
  18. F. Kehl, P. S. Pagel, J. G. Krolikowski et al., “Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo,” Anesthesia and Analgesia, vol. 95, no. 5, pp. 1162–1168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Wakeno-Takahashi, H. Otani, S. Nakao, H. Imamura, and K. Shingu, “Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 6, pp. H2585–H2591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Sogaard, C. O. Gotzsche, J. Ravkilde, and K. Thygesen, “Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction,” Circulation, vol. 87, no. 4, pp. 1093–1099, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Gurevitch, D. Pevni, I. Frolkis et al., “Captopril in cardioplegia and reperfusion: protective effects on the ischemic heart,” The Annals of Thoracic Surgery, vol. 63, no. 3, pp. 627–633, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. A. W. Scribner, J. Loscalzo, and C. Napoli, “The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress,” European Journal of Pharmacology, vol. 482, no. 1-3, pp. 95–99, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-H. Liu, Y. You, T. Song, S.-J. Wu, and L.-Y. Liu, “Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril,” Journal of Cardiovascular Pharmacology, vol. 50, no. 2, pp. 155–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. F. M. B. de Gusmão, C. Becker, M. H. C. Carvalho, and L. F. M. Barros, “Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction,” International Journal of Cardiology, vol. 100, no. 3, pp. 363–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Linz, G. Wiemer, and B. A. Scholkens, “ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts,” Journal of Molecular and Cellular Cardiology, vol. 24, no. 8, pp. 909–919, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Fan, X.-C. Yang, Y. Liu et al., “Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans,” Clinical Science, vol. 120, no. 6, pp. 251–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Xu, H. Li, M. G. Irwin et al., “Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats,” Critical Care Medicine, vol. 42, no. 8, pp. e583–e594, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. D. J. Hausenloy and D. M. Yellon, “Myocardial ischemia-reperfusion injury: a neglected therapeutic target,” The Journal of Clinical Investigation, vol. 123, no. 1, pp. 92–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Wang, X. Mao, H. Li et al., “N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes,” Free Radical Biology and Medicine, vol. 63, pp. 291–303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Vinten-Johansen, R. Jiang, J. G. Reeves, J. Mykytenko, J. Deneve, and L. J. Jobe, “Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion injury,” Hematology/Oncology Clinics of North America, vol. 21, no. 1, pp. 123–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. D. M. Yellon and D. J. Hausenloy, “Myocardial reperfusion injury,” The New England Journal of Medicine, vol. 357, no. 11, pp. 1074–1135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. G. M. Fröhlich, P. Meier, S. K. White, D. M. Yellon, and D. J. Hausenloy, “Myocardial reperfusion injury: looking beyond primary PCI,” European Heart Journal, vol. 34, no. 23, pp. 1714–1724, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. N. V. Solenkova, V. Solodushko, M. V. Cohen, and J. M. Downey, “Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 290, no. 1, pp. H441–H449, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Kin, Z.-Q. Zhao, H.-Y. Sun et al., “Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion,” Cardiovascular Research, vol. 62, no. 1, pp. 74–85, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Mao, T. Wang, Y. Liu et al., “N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats,” PLoS ONE, vol. 8, no. 7, Article ID e68949, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. A. F. van den Heuvel, W. H. van Gilst, D. J. van Veldhuisen, R. J. de Vries, P. H. Dunselman, and J. H. Kingma, “Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction. The Captopril and Thrombolysis Study (CATS) Investigators,” Journal of the American College of Cardiology, vol. 30, no. 2, pp. 400–405, 1997. View at Google Scholar
  37. P. C. Chiari, M. W. Bienengraeber, D. Weihrauch et al., “Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium,” Anesthesiology, vol. 103, no. 1, pp. 74–83, 2005. View at Publisher · View at Google Scholar · View at Scopus